What is Beyond Skin UK?

Beyond Skin UK manages 2 data types including reviews. Helps you organize, track, and share your work in 1 place for teams and solo users.

Niacinamide Cream

LIGHTWEIGHT NIACINAMIDE MOISTURISER FOR OILINESS, ENLARGED-LOOKING PORES AND UNEVEN TEXTURE

£34

PROUD TO BE

CONSULTATION-LED

Skincare is recommended after an in-clinic assessment of your skin, not in place of one.

PROFESSIONAL POSITIONING

Formulated for professional use alongside in-clinic treatments, with realistic expectations set.

EVIDENCE-LED ACTIVES

Every key active is chosen on published ingredient research, referenced on its product page.

Niacinamide Cream is a lightweight moisturiser built around niacinamide (vitamin B3), designed to hydrate while supporting the skin barrier and refining the look of texture and pores. Suited to combination and oily skin that still needs moisture, and to anyone wanting barrier support without a heavy cream.

At a Glance

FORMATLightweight moisturiser

KEY ACTIVENiacinamide (Nicotinamide)

BEST FORCombination and oily skin, uneven texture, barrier support

LAYERAfter serum, as the moisturising step

WHENAM and/or PM

What It's Designed to Do

Hydrate without a heavy or greasy feel
Support the skin barrier
Help refine the look of texture and enlarged-looking pores
Support a more even-looking tone

Key Active Ingredients

Niacinamide (Nicotinamide)

A vitamin B3 derivative, one of the most extensively studied cosmetic ingredients.

Conditions the skin, supports the barrier and helps refine the look of texture.

Humectant and emollient base

Water-binding and conditioning ingredients that carry a lightweight cream.

Helps maintain hydration without an occlusive feel.

06 — THE EVIDENCE

THE EVIDENCE, NOT JUST THE CLAIM.

Skincare marketing can make almost anything sound impressive. We would rather show you the research.

Our Evidence Library connects key active ingredients with published research so you can understand what has been studied, how it was studied, and how relevant that evidence is to the product you're using. Research on an ingredient does not automatically mean the finished Beyond Skin formulation has been clinically tested. When the evidence applies to an ingredient rather than our finished formula, we tell you. No blurred lines. No invented percentages. Just better-informed skincare.

How to Use

01Apply to cleansed skin after serum, morning and/or evening.
02Follow with broad-spectrum SPF in the morning.
03Where sensitivity occurs, reduce frequency.

Who It's For

Oily skinCombination skinCongestionUneven textureEnlarged-looking poresBarrier-conscious routines

SCIENCE & CLINICAL REFERENCES

The research behind the actives in this product

These references relate to the individual active ingredients, as studied in published research. Unless an entry says otherwise, they are not clinical trials of the finished Beyond Skin formulation — ingredient-level evidence does not mean the finished product has been clinically tested.

01
INGREDIENT
Niacinamide (Nicotinamide)
AUTHOR / STUDY
Topical niacinamide — double-blind placebo-controlled split-face study (50 women, 12 weeks).
JOURNAL
British Journal of Dermatology
YEAR
2000
EVIDENCE TYPE
HUMAN CLINICAL STUDY
WHAT WAS STUDIED
A 12-week, double-blind, placebo-controlled, split-face randomised study in 50 women aged 40–60 using a 5% niacinamide formulation reported improvements in fine lines/wrinkles, hyperpigmented spots, texture and red blotchiness. This is ingredient/formulation evidence, not testing of this cream.
RELEVANCE TO THIS INGREDIENT
For barrier support, skin conditioning and uneven-looking tone.
The study investigated a 5% niacinamide formulation. We do not imply this cream contains 5% unless the manufacturer specification confirms it.
VIEW STUDY
02
INGREDIENT
Humectant and emollient base
AUTHOR / STUDY
Humectant and emollient ingredients — review literature.
EVIDENCE TYPE
MECHANISTIC / REVIEW EVIDENCE
WHAT WAS STUDIED
Mechanistic humectant and emollient evidence.
RELEVANCE TO THIS INGREDIENT
For hydration and a comfortable, non-heavy finish.
Exact identities follow the manufacturer specification.
VIEW STUDY

We separate ingredient-level evidence from finished-product clinical evidence. Where research investigates an ingredient, we say so. Where it investigates a finished formulation, we say that too. We do not present one as the other.

WHAT TO USE IT WITH